Is TB-500 Legal in Washington State? Federal Rules, Prescription Paths, and What Patients Need to Know
HealthRX.com
No Washington permission confirmed; the federal draft is not binding
See the public record for TB-500
At a glance
- FDA approval / No FDA-approved TB-500 product, and no approved product in Canada, Australia, the UK or the European countries FDA reviewed; the European Medicines Agency has not authorized one [1]
- What it is / A synthetic 7-amino-acid fragment of thymosin beta-4 [1]
- FDA bulks lists / Not listed for state-licensed pharmacies or outsourcing facilities [2][3][6]
- Safety-risk page / 'Nominated but withdrawn' table, not an active listing [7]
- Advisory committee / Voted in favor July 23, 2026; advice only [4][8]
- HHS draft policy / Names TB-500 acetate injection; non-binding draft [4][5]
- Anti-doping / WADA prohibits it at all times [9]
Where TB-500 stands federally
FDA's July 2026 review found no USP or National Formulary monograph for TB-500, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy or authorized by the European Medicines Agency [1]. TB-500 is a synthetic 7-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, not the full-length protein [1].
It appears in none of the three categories of FDA's interim policy for state-licensed pharmacies and physicians (updated May 14, 2026) and is absent from FDA's list for outsourcing facilities (updated March 21, 2025), so that policy of generally not acting against compounders does not cover it [2][3][6]. FDA's safety-risk page lists 'Thymosin beta-4, fragment (LKKTETQ), also known as TB-500' in its 'nominated but withdrawn' table; removal was not a finding that it is safe, and FDA said it 'has not identified any human exposure data' on it [7].
The 2026 developments, and what they are not
FDA staff proposed in July 2026 that neither TB-500 free base nor TB-500 acetate be added to the pharmacy bulks list, citing unclear characterization, no evidence of effectiveness for wound healing, and no human data [1]. The Pharmacy Compounding Advisory Committee voted in favor of adding it on July 23, 2026, against staff's recommendation; the vote is advice only and not binding [4][8].
In its non-binding draft policy, HHS proposes not to take enforcement action against certain prescribers and pharmacies compounding TB-500 acetate injections if all stated conditions are met, including a patient-specific prescription [4][5]. The notice states it 'does not establish any rights for any person and is not binding on HHS or the public' [4].
What people on Reddit report
Reddit users discussing the federal enforcement discretion policy for six compounded peptides. Accounts range from people who see it as a legal route to people who expect prices to rise or access to narrow.
This is a pathway for more LEGIT access. Im sorry but this RUO business is saturated with "Gym Bro Joe" slinging god knows whatRead the source discussion
If they wipe out the "RUO's" people will be left with no choice but to pay extravagant prices that they can't afford. Many won't even get a prescription or approved for these peptides.Read the source discussion
The RUO side is not going anywhere. The pharmacies and med spas will charge way more than an RUO site.Read the source discussion
It's 503A only. 503B outsourcing facilities aren't covered, so no office-use stock or big batch production. Every fill is patient-specific off a script.Read the source discussion
Questions worth asking
Safety: what is known
There is no approved dose and no human dosing study; the nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for injection [1]. FDA found no published article in which TB-500 was given to a person, and its adverse-event database search through March 26, 2025 retrieved no TB-500 reports [1]. Safety in humans is unknown; FDA's stated concern for injectable TB-500 is immunogenicity, possibly amplified by aggregation and impurities [1].
Athletes
WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3 and prohibits it at all times, in and out of competition; it is on the 2026 List and stays on the 2027 List [9][10]. Compounded drugs, even when made under an enforcement-discretion policy, are not FDA-approved [4].
Frequently asked questions
Is TB-500 legal in Washington State?
Does TB-500 require a prescription?
Did FDA approve TB-500 for compounding in 2026?
Is TB-500 the same as thymosin beta-4?
Can athletes use TB-500?
References
Show all 11 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- Official web page.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- Reddit participants. Six peptides got a legal route today. The restrictions are tighter than the headlines, and here is my read on what the research-use market d (r/TeleMedicine). Accessed 2026-11-11.